Cargando…
More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response
Estrogen receptor α (ER) is a major driver of breast cancer and the target of endocrine therapy. Full disclosure of the cofactors regulating ER interactions with chromatin and its transcriptional regulatory activity is still elusive. Novel genome-wide profiling tools have mapped ER binding events in...
Autores principales: | Fu, Xiaoyong, Huang, Catherine, Schiff, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219191/ https://www.ncbi.nlm.nih.gov/pubmed/21575280 http://dx.doi.org/10.1186/bcr2849 |
Ejemplares similares
-
To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression
por: Watters, Rebecca J, et al.
Publicado: (2012) -
Estrogen receptor degradation: a CUE for endocrine resistance?
por: Musgrove, Elizabeth A
Publicado: (2011) -
FOXA1 is a critical determinant of Estrogen Receptor function and endocrine response
por: Hurtado, Antoni, et al.
Publicado: (2010) -
Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression
por: Thanan, Raynoo, et al.
Publicado: (2020) -
A functional link between FOXA1 and breast cancer SNPs
por: Katika, Madhumohan R, et al.
Publicado: (2013)